Reducing the nicotine content of combusted tobacco products sold in New Zealand

Eric C. Donny, Natalie Walker, Dorothy Hatsukami, Chris Bullen

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Large reductions in nicotine content could dramatically reduce reinforcement from and dependence on cigarettes. In this article, we summarise the potential benefits of reducing nicotine in combusted tobacco and address some of the common concerns. We focus specifically on New Zealand because it may be ideally situated to implement such a policy. The available data suggest that, in current smokers, very low nicotine content (VLNC) cigarettes decrease nicotine exposure, decrease cigarette dependence, reduce the number of cigarettes smoked per day and increase the likelihood of contemplating, making and succeeding at a quit attempt. New smokers would almost certainly be exposed to far less nicotine as a result of smoking VLNC cigarettes and, consequently, would probably be less likely to become chronic, dependent, smokers. Many of the concerns about reducing nicotine including compensatory smoking, an exacerbation of psychiatric symptoms, the perception that VLNC cigarettes are less harmful, and the potential for a black market are either not supported by the available data, likely mitigated by other factors including the availability of nicotinecontaining e-cigarettes, or unlikely to offset the potential benefit to public health. Although not all concerns have been addressed or can be a priori, the magnitude of the potential benefits and the growing evidence of relatively few potential harms should make nicotine reduction one of the centrepieces for discussion of how to rapidly advance tobacco control. Policies that aim to render the most toxic tobacco products less addictive could help New Zealand attain their goal of becoming smokefree by 2025.

Original languageEnglish (US)
Pages (from-to)e37-e42
JournalTobacco control
Volume26
Issue numbere1
DOIs
StatePublished - 2017

Bibliographical note

Funding Information:
Acknowledgements ECD was supported by the University of Pittsburgh while

Funding Information:
writing this manuscript as a Visiting Professor at the University of Auckland. DH was supported by the Forster Family Chair in Cancer Prevention. ECD and DH receive research funding from the US National Institute on Drug Abuse and the Food and Drug Administration Center for Tobacco Products to assess the potential impact of reducing the nicotine content of cigarettes in the USA.

Funding Information:
Funding Contributions from all authors were supported by their respective institutions.

Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Reducing the nicotine content of combusted tobacco products sold in New Zealand'. Together they form a unique fingerprint.

Cite this